Accurate Wealth Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$635K Buy
2,026
+346
+21% +$107K 0.05% 319
2026
Q2
$465K Buy
1,680
+276
+20% +$72.6K 0.04% 370
2026
Q1
$366K Buy
1,404
+43
+3% +$11.6K 0.04% 382
2025
Q4
$343K Buy
1,361
+117
+9% +$31.1K 0.04% 372
2025
Q3
$348K Buy
1,244
+143
+13% +$38.3K 0.05% 364
2025
Q2
$279K Buy
1,101
+74
+7% +$18K 0.04% 366
2025
Q1
$227K Buy
+1,027
New +$249K 0.04% 346
2023
Q1
– Sell
-289
Closed -$60.8K – 902
2022
Q4
$60.8K Buy
+289
New +$56.5K 0.02% 414

Other funds holding LH

Accurate Wealth Management's LH Position: Q3 2026 in Review

Accurate Wealth Management increased its Labcorp (LH) stake by 21% in Q3 2026, buying an estimated $107K and bringing the position to 2,026 shares worth $635K. The position accounts for 0.05% of the portfolio, ranked #319.

Accurate Wealth Management first reported a position in LH in Q4 2022 and has held it in 8 quarters since. 549 funds tracked by Wall St. Rank hold LH as of Q3 2026.

  • Accurate Wealth Management held 2,026 shares of Labcorp worth $635K as of Q3 2026.
  • Accurate Wealth Management bought 346 Labcorp shares in Q3 2026, an estimated $107K.
  • Labcorp made up 0.05% of Accurate Wealth Management's portfolio in Q3 2026, its #319 holding.
  • Accurate Wealth Management first reported a position in Labcorp in Q4 2022 and has held it in 8 quarters since.
  • 549 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.

Based on Accurate Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.